Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A DNA minor groove crosslinker is a molecule that binds within the minor groove of the DNA double helix and forms covalent bonds (crosslinks) between two strands of DNA. This action can disrupt essential cellular processes such as replication and transcription, making these agents important in both research and therapeutic contexts, particularly as chemotherapeutic drugs. Crosslinked DNA is highly cytotoxic because it impedes essential cellular processes. Cells repair these lesions using complex pathways involving nucleotide excision repair (NER), homologous recombination (HR), base excision repair (BER), and specific endonucleases like XPF–ERCC1 for unhooking crosslinks. DNA minor-groove crosslinkers are used as anticancer agents due to their ability to induce cytotoxic lesions selectively in rapidly dividing cells. Their effectiveness depends on their ability to form stable adducts at specific genomic sites.
Covalent interstrand crosslinking within the DNA minor groove, preventing strand separation and inhibiting replication and transcription.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Minor Groove Crosslinker.